Voloridge Health provides data-driven insights from blood, genetics, and proteomics to unlock a deeper understanding of Stolz’s health and performance in speed skating and beyond.

• Stolz is one of the sport’s brightest stars, capturing 51 World Cup medals including 37 first-place finishes, was crowned the overall World Cup champion in the 500m, 1000m, 1500m last year, and holds the world record in the 1,000m.
• Voloridge Health applies advanced data science to health, integrating diverse health data sources to deliver personalized wellness strategies.
• Voloridge Health and Jordan Stolz share a vision of unlocking human potential and extending longevity in sport and life through the power of data. The partnership reflects not only a commitment to athletic excellence but a broader mission of enabling longer, healthier lives.

Voloridge Health, LLC, a data science company dedicated to empowering individuals and organizations to transform health with data-driven insights, is proud to announce a strategic partnership with World Champion speed skater Jordan Stolz.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251212004171/en/

Voloridge Health provides data-driven insights to unlock a deeper understanding of Jordan Stolz’s health and performance in speed skating and beyond. (PHOTO CREDIT: US SPEEDSKATING)

At just 21 years old, Stolz has quickly established himself as one of the most dominant figures in long track speed skating. The current world record holder in the 1000m, he captured the 2024 World Allaround Championships to become the youngest male to claim the crown in 46 years. He won gold at the 2023 World Speed Skating Championships in 2023, becoming the youngest single distance winner in history. In 2023, he became the first male skater to win three individual gold medals at a single World Speed Skating Championships, a feat he repeated in 2024. Stolz is the first person to win titles in three separate distances at the Senior and Junior World Champions in the same year, which he accomplished in 2023. The Wisconsin-native learned to skate on his backyard pond as a child and today is widely recognized as one of the sport’s most promising and accomplished athletes.

“Jordan exemplifies the values of discipline and excellence, which align perfectly with Voloridge Health’s mission,” said David S. Vogel, CEO of Voloridge Health. “His commitment to using data to push the boundaries of his training and performance mirrors our own approach. We are excited to support Jordan by providing advanced insights from blood, genetics, and proteomics testing – modalities that bring new understanding to the world of speed skating. With these tools, we look forward to helping him elevate his performance on the ice.”

Voloridge Health builds advanced analytical tools, turning complex health data into proactive insights, to try to help people optimize their health. By integrating multivariate data, they uncover patterns and relationships in the data points. These insights can translate into personalized health strategies, empowering individuals to improve their well-being.

“I’m thrilled to collaborate with Voloridge Health,” said Stolz. “Their innovative approach to improve health with data resonates with me as an athlete who relies on precision and analytics to perform my best. Every stride I take is measured, every split time analyzed, every detail accounted for – that’s how I compete at the highest level. Voloridge’s data science expertise and focus on diverse health indicators that I haven’t measured before equip me with key knowledge to inform my training plan, as now I will have additional metrics from the inside out.”

About Voloridge Health, LLC

Voloridge Health is a data science-driven company committed to transforming the future of healthcare through advanced predictive analytics. Its mission is to empower individuals and organizations to achieve longer, healthier lives with actionable, data-driven health insights. Built on a proven track record of modeling complex systems through its affiliate Voloridge Investment Management, LLC, Voloridge Health applies the same analytical rigor to predictive health, developing advanced tools and software that enable more informed, personalized health decisions. The company also invests in innovative health technologies and partners with visionary teams that share its commitment to preventive and precision care. Learn more at www.voloridgehealth.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251212004171/en/

Voloridge Health and Jordan Stolz share a vision of unlocking human potential and extending longevity in sport and life through the power of data.